CASP3 and cancer: In the middle panel, a representative tumor tissue of the SPESN38-8 treatment group from the bottom panel of Fig. 9A from showed reduced cancer cell density and lower Ki67 but higher cleaved caspase 3 levels relative to the left panel, indicating the antitumor effect by SPESN38-8.